111 results on '"Rigobello MP"'
Search Results
2. Rapid and efficient purification of hypericin and pseudohypericin and inhibition of thioredoxin reductase
- Author
-
Karioti, A, primary, Sorrentino, F, additional, Gratteri, P, additional, Rigobello, MP, additional, Scutari, G, additional, Messori, L, additional, Bindoli, A, additional, Bergonzi, MC, additional, and Bilia, AR, additional
- Published
- 2009
- Full Text
- View/download PDF
3. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
- Author
-
Egea, J, Fabregat, I, Frapart, YM, Ghezzi, P, Görlach, A, Kietzmann, T, Kubaichuk, K, Knaus, UG, Lopez, MG, Olaso-Gonzalez, G, Petry, A, Schulz, R, Vina, J, Winyard, P, Abbas, K, Ademowo, OS, Afonso, CB, Andreadou, I, Antelmann, H, Antunes, F, Aslan, M, Bachschmid, MM, Barbosa, RM, Belousov, V, Berndt, C, Bernlohr, D, Bertrán, E, Bindoli, A, Bottari, SP, Brito, PM, Carrara, G, Casas, AI, Chatzi, A, Chondrogianni, N, Conrad, M, Cooke, MS, Costa, JG, Cuadrado, A, My-Chan Dang, P, De Smet, B, Debelec-Butuner, B, Dias, IHK, Dunn, JD, Edson, AJ, El Assar, M, El-Benna, J, Ferdinandy, P, Fernandes, AS, Fladmark, KE, Förstermann, U, Giniatullin, R, Giricz, Z, Görbe, A, Griffiths, H, Hampl, V, Hanf, A, Herget, J, Hernansanz-Agustín, P, Hillion, M, Huang, J, Ilikay, S, Jansen-Dürr, P, Jaquet, V, Joles, JA, Kalyanaraman, B, Kaminskyy, D, Karbaschi, M, Kleanthous, M, Klotz, L-O, Korac, B, Korkmaz, KS, Koziel, R, Kračun, D, Krause, K-H, Křen, V, Krieg, T, Laranjinha, J, Lazou, A, Li, H, Martínez-Ruiz, A, Matsui, R, McBean, GJ, Meredith, SP, Messens, J, Miguel, V, Mikhed, Y, Milisav, I, Milković, L, Miranda-Vizuete, A, Mojović, M, Monsalve, M, Mouthuy, P-A, Mulvey, J, Münzel, T, Muzykantov, V, Nguyen, ITN, Oelze, M, Oliveira, NG, Palmeira, CM, Papaevgeniou, N, Pavićević, A, Pedre, B, Peyrot, F, Phylactides, M, Pircalabioru, GG, Pitt, AR, Poulsen, HE, Prieto, I, Rigobello, MP, Robledinos-Antón, N, Rodríguez-Mañas, L, Rolo, AP, Rousset, F, Ruskovska, T, Saraiva, N, Sasson, S, Schröder, K, Semen, K, Seredenina, T, Shakirzyanova, A, Smith, GL, Soldati, T, Sousa, BC, Spickett, CM, Stancic, A, Stasia, MJ, Steinbrenner, H, Stepanić, V, Steven, S, Tokatlidis, K, Tuncay, E, Turan, B, Ursini, F, Vacek, J, Vajnerova, O, Valentová, K, Van Breusegem, F, Varisli, L, Veal, EA, Yalçın, AS, Yelisyeyeva, O, Žarković, N, Zatloukalová, M, Zielonka, J, Touyz, RM, Papapetropoulos, A, Grune, T, Lamas, S, Schmidt, HHHW, Di Lisa, F, and Daiber, A
- Subjects
reactive oxygen species ,antioxidants ,reactive nitrogen species ,redox therapeutics ,oxidative stress ,redox signaling ,3. Good health - Abstract
The European Cooperation in Science and Technology (COST) provides an ideal framework to establish multi-disciplinary research networks. COST Action BM1203 (EU-ROS) represents a consortium of researchers from different disciplines who are dedicated to providing new insights and tools for better understanding redox biology and medicine and, in the long run, to finding new therapeutic strategies to target dysregulated redox processes in various diseases. This report highlights the major achievements of EU-ROS as well as research updates and new perspectives arising from its members. The EU-ROS consortium comprised more than 140 active members who worked together for four years on the topics briefly described below. The formation of reactive oxygen and nitrogen species (RONS) is an established hallmark of our aerobic environment and metabolism but RONS also act as messengers via redox regulation of essential cellular processes. The fact that many diseases have been found to be associated with oxidative stress established the theory of oxidative stress as a trigger of diseases that can be corrected by antioxidant therapy. However, while experimental studies support this thesis, clinical studies still generate controversial results, due to complex pathophysiology of oxidative stress in humans. For future improvement of antioxidant therapy and better understanding of redox-associated disease progression detailed knowledge on the sources and targets of RONS formation and discrimination of their detrimental or beneficial roles is required. In order to advance this important area of biology and medicine, highly synergistic approaches combining a variety of diverse and contrasting disciplines are needed.
4. By-Products Valorization: Peptide Fractions from Milk Permeate Exert Antioxidant Activity in Cellular and In Vivo Models.
- Author
-
Scalcon V, Fiorese F, Albanesi M, Folda A, Betti G, Bellamio M, Feller E, Lodovichi C, Arrigoni G, Marin O, and Rigobello MP
- Abstract
The discarding of agri-food by-products is a stringent problem due to their high environmental impact. Recovery strategies can lead to a reduction of waste and result in new applications. Agri-food waste represents a source of bioactive molecules, which could promote health benefits. The primary goal of this research has been the assessment of the antioxidant activity of milk permeate, a dairy farm by-product, and the isolation and identification of peptide fractions endowed with antioxidant activity. The chromatographic extraction of the peptide fractions was carried out, and the peptides were identified by mass spectrometry. The fractions showed radical scavenging activity in vitro. Moreover, the results in the Caco-2 cell model demonstrated that the peptide fractions were able to protect from oxidative stress by stimulating the Keap1/Nrf2 antioxidant signaling pathway, increasing the transcription of antioxidant enzymes. In addition, the bioactive peptides can affect cellular metabolism, increasing mitochondrial respiration. The action of the peptide fractions was also assessed in vivo on a zebrafish model and resulted in the protection of the whole organism from the adverse effects of acute cold stress, highlighting their strong capability to protect from an oxidative insult. Altogether, the results unveil novel recovery strategies for food by-products as sources of antioxidant bioactive peptides that might be utilized for the development of functional foods.
- Published
- 2024
- Full Text
- View/download PDF
5. Thiamine disulfide derivatives in thiol redox regulation: Role of thioredoxin and glutathione systems.
- Author
-
Folda A, Scalcon V, Tonolo F, Rigobello MP, and Bindoli A
- Abstract
Thiamine (vitamin B1), under the proper conditions, is able to reversibly open the thiazole ring, forming a thiol-bearing molecule that can be further oxidized to the corresponding disulfide. To improve the bioavailability of the vitamin, several derivatives of thiamine in the thioester or disulfide form were developed and extensively studied over time, as apparent from the literature. We have examined three thiamine-derived disulfides: thiamine disulfide, sulbutiamine, and fursultiamine with reference to their intervention in modulating the thiol redox state. First, we observed that both glutathione and thioredoxin (Trx) systems were able to reduce the three disulfides. In particular, thioredoxin reductase (TrxR) reduced these disulfides either directly or in the presence of Trx. In Caco-2 cells, the thiamine disulfide derivatives did not modify the total thiol content, which, however, was significantly decreased by the concomitant inhibition of TrxR. When oxidative stress was induced by tert-butyl hydroperoxide, the thiamine disulfides exerted a protective effect, indicating that the thiol form deriving from the reduction of the disulfides might be the active species. Further, the thiamine disulfides examined were shown to increase the nuclear levels of the transcription factor nuclear factor erythroid 2 related factor 2 and to stimulate both expression and activity of NAD(P)H quinone dehydrogenase 1 and TrxR. However, other enzymes of the glutathione and Trx systems were scarcely affected. As the thiol redox balance plays a critical role in oxidative stress and inflammation, the information presented can be of interest for further research, considering the potential favorable effect exerted in the cell by many sulfur compounds, including the thiamine-derived disulfides., (© 2024 The Author(s). BioFactors published by Wiley Periodicals LLC on behalf of International Union of Biochemistry and Molecular Biology.)
- Published
- 2024
- Full Text
- View/download PDF
6. Bioactive peptides from food waste: New innovative bio-nanocomplexes to enhance cellular uptake and biological effects.
- Author
-
Tonolo F, Fiorese F, Rilievo G, Grinzato A, Latifidoost Z, Nikdasti A, Cecconello A, Cencini A, Folda A, Arrigoni G, Marin O, Rigobello MP, Magro M, and Vianello F
- Subjects
- Humans, Caco-2 Cells, Animals, Cattle, Oxidative Stress drug effects, Whey chemistry, Female, Tandem Mass Spectrometry, Food Loss and Waste, Peptides chemistry, Waste Products analysis
- Abstract
Mastitis is the most important bovine disease, causing dramatic economic losses to the dairy industry, worldwide. This study explores the valorization of whey from cows affected by mastitis, through a novel separation approach. Surface Active Maghemite Nanoparticles (SAMNs) were used as magnetic baits to selectively bind bioactive peptides with potential health benefits. Advanced techniques such as HPLC and LC-MS/MS highlighted SAMN capability of isolating a restricted group of peptides, drastically diverging from the control profile (Solid Phase Extraction, SPE) and characterized by a peculiar acidic residue distribution. Most importantly, both magnetically purified and nano-immobilized peptides (SAMN@peptides) showed protective activity against oxidative stress and inflammation, when tested on Caco-2 cells; with SAMN@peptides being associated with the strongest biological effect. SAMNs exhibited excellent characteristics, they are environmentally sustainable, and their synthesis is cost-effective prompting at a scalable and selective tool for capturing bioactive peptides, with potential applications in functional foods and nutraceuticals., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF
7. The Role of Antioxidant Foods and Nutraceuticals in Ageing.
- Author
-
Giorgio M and Rigobello MP
- Abstract
The free radical theory of aging proposed by Denham Harman in the 1950s identified the accumulation of oxidative damage over time as a cause of aging [...].
- Published
- 2024
- Full Text
- View/download PDF
8. Sunflower seed-derived bioactive peptides show antioxidant and anti-inflammatory activity: From in silico simulation to the animal model.
- Author
-
Tonolo F, Coletta S, Fiorese F, Grinzato A, Albanesi M, Folda A, Ferro S, De Mario A, Piazza I, Mammucari C, Arrigoni G, Marin O, Cestonaro G, Nataloni L, Costanzo E, Lodovichi C, Rigobello MP, and de Bernard M
- Subjects
- Animals, Kelch-Like ECH-Associated Protein 1 genetics, Kelch-Like ECH-Associated Protein 1 metabolism, NF-E2-Related Factor 2 genetics, NF-E2-Related Factor 2 metabolism, Zebrafish metabolism, Peptides pharmacology, Peptides metabolism, Anti-Inflammatory Agents pharmacology, Models, Animal, Computer Simulation, Antioxidants chemistry, Helianthus metabolism
- Abstract
The evolving field of food technology is increasingly dedicated to developing functional foods. This study explored bioactive peptides from sunflower protein isolate (SPI), obtained from defatted flour, a by-product of the oil processing industry. SPI underwent simulated gastrointestinal digestion and the obtained peptide-enriched fraction (PEF) showed antioxidant properties in vivo, in zebrafish. Among the peptides present in PEF identified by mass spectrometry analysis, we selected those with antioxidant properties by in silico evaluation, considering their capability to interact with Keap1, key protein in the regulation of antioxidant response. The selected peptides were synthesized and evaluated in a cellular model. As a result, DVAMPVPK, VETGVIKPG, TTHTNPPPEAE, LTHPQHQQQGPSTG and PADVTPEEKPEV activated Keap1/Nrf2 pathway leading to Antioxidant Response Element-regulated enzymes upregulation. Since the crosstalk between Nrf2 and NF-κB is well known, the potential anti-inflammatory activity of the peptides was assessed and principally PADVTPEEKPEV showed good features both as antioxidant and anti-inflammatory molecule., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Enrico Costanzo, Luigi Nataloni and Giulia Cestonaro (Cereal Docks S.p.A.) has patent # IT102022000016812 pending to Assignee., (Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
9. Exploring the Anticancer Activity of Tamoxifen-Based Metal Complexes Targeting Mitochondria.
- Author
-
Scalcon V, Bonsignore R, Aupič J, Thomas SR, Folda A, Heidecker AA, Pöthig A, Magistrato A, Casini A, and Rigobello MP
- Subjects
- Humans, Female, Tamoxifen metabolism, Mitochondria, Receptors, Estrogen metabolism, Cell Line, Tumor, Coordination Complexes chemistry, Antineoplastic Agents therapeutic use, Breast Neoplasms drug therapy, Breast Neoplasms metabolism
- Abstract
Two new 'hybrid' metallodrugs of Au(III) (AuTAML) and Cu(II) (CuTAML) were designed featuring a tamoxifen-derived pharmacophore to ideally synergize the anticancer activity of both the metal center and the organic ligand. The compounds have antiproliferative effects against human MCF-7 and MDA-MB 231 breast cancer cells. Molecular dynamics studies suggest that the compounds retain the binding activity to estrogen receptor (ERα) . In vitro and in silico studies showed that the Au(III) derivative is an inhibitor of the seleno-enzyme thioredoxin reductase, while the Cu(II) complex may act as an oxidant of different intracellular thiols. In breast cancer cells treated with the compounds, a redox imbalance characterized by a decrease in total thiols and increased reactive oxygen species production was detected. Despite their different reactivities and cytotoxic potencies, a great capacity of the metal complexes to induce mitochondrial damage was observed as shown by their effects on mitochondrial respiration, membrane potential, and morphology.
- Published
- 2023
- Full Text
- View/download PDF
10. From In Silico to a Cellular Model: Molecular Docking Approach to Evaluate Antioxidant Bioactive Peptides.
- Author
-
Tonolo F, Grinzato A, Bindoli A, and Rigobello MP
- Abstract
The increasing need to counteract the redox imbalance in chronic diseases leads to focusing research on compounds with antioxidant activity. Among natural molecules with health-promoting effects on many body functions, bioactive peptides are gaining interest. They are protein fragments of 2-20 amino acids that can be released by various mechanisms, such as gastrointestinal digestion, food processing and microbial fermentation. Recent studies report the effects of bioactive peptides in the cellular environment, and there is evidence that these compounds can exert their action by modulating specific pathways. This review focuses on the newest approaches to the structure-function correlation of the antioxidant bioactive peptides, considering their molecular mechanism, by evaluating the activation of specific signaling pathways that are linked to antioxidant systems. The correlation between the results of in silico molecular docking analysis and the effects in a cellular model was highlighted. This knowledge is fundamental in order to propose the use of bioactive peptides as ingredients in functional foods or nutraceuticals.
- Published
- 2023
- Full Text
- View/download PDF
11. Mitochondrial depletion of glutaredoxin 2 induces metabolic dysfunction-associated fatty liver disease in mice.
- Author
-
Scalcon V, Folda A, Lupo MG, Tonolo F, Pei N, Battisti I, Ferri N, Arrigoni G, Bindoli A, Holmgren A, Coppo L, and Rigobello MP
- Subjects
- Animals, Mice, Mitochondria genetics, Mitochondria metabolism, Proteins metabolism, Glutaredoxins genetics, Glutaredoxins metabolism, Liver Diseases metabolism
- Abstract
Glutaredoxin 2 (Grx2) is a glutathione-dependent oxidoreductase that facilitates glutathionylation/de-glutathionylation of target proteins. The main variants of Grx2 are the mitochondrial Grx2a and the cytosolic Grx2c. The aim of this study was to investigate the specific role of mitochondrial Grx2 in vivo using a mitochondrial Grx2 depleted (mGD) mouse model. mGD mice displayed an altered mitochondrial morphology and functioning. Furthermore, the lack of Grx2 in the mitochondrial compartment is responsible for increased blood lipid levels under a normal diet, a metabolic dysfunction-associated fatty liver disease (MAFLD) phenotype and a decreased glycogen storage capacity. In addition, depleting Grx2a leads to an alteration in abundance and in glutathionylation pattern of different mitochondrial enzymes, highlighting the selective role of Grx2 in the regulation of metabolic pathways. Overall, our findings identify the involvement of mitochondrial Grx2a in the regulation of cell metabolism and highlight a previously unknown association between Grx2 and MAFLD., (Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
12. Nrf2-Activating Bioactive Peptides Exert Anti-Inflammatory Activity through Inhibition of the NF-κB Pathway.
- Author
-
Tonolo F, Folda A, Scalcon V, Marin O, Bindoli A, and Rigobello MP
- Subjects
- Anti-Inflammatory Agents pharmacology, Anti-Inflammatory Agents therapeutic use, Caco-2 Cells, Heme Oxygenase-1 genetics, Heme Oxygenase-1 metabolism, Humans, Inflammation drug therapy, Inflammation metabolism, Kelch-Like ECH-Associated Protein 1 genetics, Kelch-Like ECH-Associated Protein 1 metabolism, Lipopolysaccharides pharmacology, Signal Transduction, Tumor Necrosis Factor-alpha metabolism, NF-E2-Related Factor 2 genetics, NF-E2-Related Factor 2 metabolism, NF-kappa B metabolism
- Abstract
Redox status and inflammation are related to the pathogenesis of the majority of diseases. Therefore, understanding the role of specific food-derived molecules in the regulation of their specific pathways is a relevant issue. Our previous studies indicated that K-8-K and S-10-S , milk and soy-derived bioactive peptides, respectively, exert antioxidant effects through activation of the Keap1/Nrf2 pathway. A crosstalk between Nrf2 and NF-κB, mediated by the action of heme oxygenase (HO-1), is well known. On this basis, we studied if these peptides, in addition to their antioxidant activity, could exert anti-inflammatory effects in human cells. First, we observed an increase of HO-1 expression in Caco-2 cells treated with K-8-K and S-10-S , following the activation of the Keap1/Nrf2 pathway. Moreover, when cells are treated with the two peptides and stimulated by TNF-α, the levels of NF-κB in the nucleus decreased in comparison with TNF-α alone. In the same conditions, we observed the downregulation of the gene expression of proinflammatory cytokines ( IL1B , IL6 , and TNF ), while the anti-inflammatory cytokine gene, IL1RN , was upregulated in Caco-2 cells processed as reported above. Then, when the cells were pretreated with the two peptides and stimulated with LPS, a different proinflammatory factor, (TNF-α) was estimated to have a lower secretion in the supernatant of cells. In conclusion, these observations confirmed that Nrf2-activating bioactive peptides, K-8-K and S-10-S , exerted anti-inflammatory effects by inhibiting the NF-κB pathway.
- Published
- 2022
- Full Text
- View/download PDF
13. SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells.
- Author
-
Peggion C, Scalcon V, Massimino ML, Nies K, Lopreiato R, Rigobello MP, and Bertoli A
- Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the loss of motor neurons in the brain and spinal cord. While the exact causes of ALS are still unclear, the discovery that familial cases of ALS are related to mutations in the Cu/Zn superoxide dismutase (SOD1), a key antioxidant enzyme protecting cells from the deleterious effects of superoxide radicals, suggested that alterations in SOD1 functionality and/or aberrant SOD1 aggregation strongly contribute to ALS pathogenesis. A new scenario was opened in which, thanks to the generation of SOD1 related models, different mechanisms crucial for ALS progression were identified. These include excitotoxicity, oxidative stress, mitochondrial dysfunctions, and non-cell autonomous toxicity, also implicating altered Ca
2+ metabolism. While most of the literature considers motor neurons as primary target of SOD1-mediated effects, here we mainly discuss the effects of SOD1 mutations in non-neuronal cells, such as glial and skeletal muscle cells, in ALS. Attention is given to the altered redox balance and Ca2+ homeostasis, two processes that are strictly related with each other. We also provide original data obtained in primary myocytes derived from hSOD1(G93A) transgenic mice, showing perturbed expression of Ca2+ transporters that may be responsible for altered mitochondrial Ca2+ fluxes. ALS-related SOD1 mutants are also responsible for early alterations of fundamental biological processes in skeletal myocytes that may impinge on skeletal muscle functions and the cross-talk between muscle cells and motor neurons during disease progression.- Published
- 2022
- Full Text
- View/download PDF
14. New Platinum(II) Complexes Affecting Different Biomolecular Targets in Resistant Ovarian Carcinoma Cells.
- Author
-
Hyeraci M, Scalcon V, Folda A, Labella L, Marchetti F, Samaritani S, Rigobello MP, and Dalla Via L
- Subjects
- Antineoplastic Agents chemical synthesis, Antineoplastic Agents chemistry, Cell Proliferation drug effects, Drug Screening Assays, Antitumor, Female, Humans, Membrane Potential, Mitochondrial drug effects, Molecular Structure, Organoplatinum Compounds chemical synthesis, Organoplatinum Compounds chemistry, Ovarian Neoplasms pathology, Tumor Cells, Cultured, Antineoplastic Agents pharmacology, Drug Resistance, Neoplasm drug effects, Organoplatinum Compounds pharmacology, Ovarian Neoplasms drug therapy
- Abstract
Resistance to platinum-based anticancer drugs represents an important limit for their clinical effectiveness and one of the most important field of investigation in the context of platinum compounds. From our previous studies, Pt
II complexes containing the triphenylphosphino moiety have been emerging as promising agents, showing significant cytotoxicity to resistant ovarian carcinoma cells. Two brominated triphenylphosphino trans-platinum derivatives were prepared and evaluated on human tumor cell lines, sensitive and resistant to cisplatin. The new complexes exert a notable antiproliferative effect on resistant ovarian carcinoma cells, showing a remarkable intracellular accumulation and the ability to interact with different intracellular targets. The interaction with DNA, the collapse of mitochondrial transmembrane potential, and the impairment of intracellular redox state were demonstrated. Moreover, a selectivity towards the selenocysteine of thioredoxin reductase was observed. The mechanism of action is discussed with regard to the resistance phenomenon in ovarian carcinoma cells., (© 2021 The Authors. ChemMedChem published by Wiley-VCH GmbH.)- Published
- 2021
- Full Text
- View/download PDF
15. The Determining Role of Mitochondrial Reactive Oxygen Species Generation and Monoamine Oxidase Activity in Doxorubicin-Induced Cardiotoxicity.
- Author
-
Antonucci S, Di Sante M, Tonolo F, Pontarollo L, Scalcon V, Alanova P, Menabò R, Carpi A, Bindoli A, Rigobello MP, Giorgio M, Kaludercic N, and Di Lisa F
- Subjects
- Animals, Heart Ventricles metabolism, Mice, Mitochondria, Myocytes, Cardiac metabolism, Oxidative Stress drug effects, Rats, Reactive Oxygen Species analysis, Doxorubicin pharmacology, Heart Ventricles drug effects, Monoamine Oxidase metabolism, Myocytes, Cardiac drug effects, Reactive Oxygen Species metabolism
- Abstract
Aims: Doxorubicin cardiomyopathy is a lethal pathology characterized by oxidative stress, mitochondrial dysfunction, and contractile impairment, leading to cell death. Although extensive research has been done to understand the pathophysiology of doxorubicin cardiomyopathy, no effective treatments are available. We investigated whether monoamine oxidases (MAOs) could be involved in doxorubicin-derived oxidative stress, and in the consequent mitochondrial, cardiomyocyte, and cardiac dysfunction. Results: We used neonatal rat ventricular myocytes (NRVMs) and adult mouse ventricular myocytes (AMVMs). Doxorubicin alone ( i.e. , 0.5 μ M doxorubicin) or in combination with H
2 O2 induced an increase in mitochondrial formation of reactive oxygen species (ROS), which was prevented by the pharmacological inhibition of MAOs in both NRVMs and AMVMs. The pharmacological approach was supported by the genetic ablation of MAO-A in NRVMs. In addition, doxorubicin-derived ROS caused lipid peroxidation and alterations in mitochondrial function ( i.e. , mitochondrial membrane potential, permeability transition, redox potential), mitochondrial morphology ( i.e. , mitochondrial distribution and perimeter), sarcomere organization, intracellular [Ca2+ ] homeostasis, and eventually cell death. All these dysfunctions were abolished by MAO inhibition. Of note, in vivo MAO inhibition prevented chamber dilation and cardiac dysfunction in doxorubicin-treated mice. Innovation and Conclusion: This study demonstrates that the severe oxidative stress induced by doxorubicin requires the involvement of MAOs, which modulate mitochondrial ROS generation. MAO inhibition provides evidence that mitochondrial ROS formation is causally linked to all disorders caused by doxorubicin in vitro and in vivo . Based upon these results, MAO inhibition represents a novel therapeutic approach for doxorubicin cardiomyopathy.- Published
- 2021
- Full Text
- View/download PDF
16. Fermented Soy-Derived Bioactive Peptides Selected by a Molecular Docking Approach Show Antioxidant Properties Involving the Keap1/Nrf2 Pathway.
- Author
-
Tonolo F, Moretto L, Grinzato A, Fiorese F, Folda A, Scalcon V, Ferro S, Arrigoni G, Bellamio M, Feller E, Bindoli A, Marin O, and Rigobello MP
- Abstract
Bioactive peptides are a group of molecules with health beneficial properties, deriving from food matrices. They are protein fragments consisting of 2-20 amino acids that can be released by microbial fermentation, food processing and gastrointestinal digestion. Once hydrolyzed from their native proteins, they can have different functions including antioxidant activity, which is important for cell protection by oxidant agents. In this work, fermented soy products were digested in vitro in order to improve the release of bioactive peptides. These were extracted, purified and analyzed in vitro and in a cellular model to assess their antioxidant activity. Peptide sequences were identified by LC-MS/MS analysis and a molecular docking approach was used to predict their ability to interact with Keap1, one of the key proteins of the Keap1/Nrf2 pathway, the major system involved in redox regulation. Peptides showing a high score of interaction were selected and tested for their antioxidant properties in a cellular environment using the Caco-2 cell line and examined for their capability to defend cells against oxidative stress. Our results indicate that several of the selected peptides were indeed able to activate the Keap1/Nrf2 pathway with the consequent overexpression of antioxidant and phase II enzymes.
- Published
- 2020
- Full Text
- View/download PDF
17. Platinum(II) Complexes Bearing Triphenylphosphine and Chelating Oximes: Antiproliferative Effect and Biological Profile in Resistant Cells.
- Author
-
Hyeraci M, Colalillo M, Labella L, Marchetti F, Samaritani S, Scalcon V, Rigobello MP, and Dalla Via L
- Subjects
- Animals, Antineoplastic Agents chemical synthesis, Antineoplastic Agents chemistry, Cell Proliferation drug effects, Cells, Cultured, Chelating Agents chemical synthesis, Chelating Agents chemistry, DNA chemistry, Dose-Response Relationship, Drug, Drug Screening Assays, Antitumor, Humans, Male, Membrane Potential, Mitochondrial drug effects, Molecular Structure, Organophosphorus Compounds chemistry, Organoplatinum Compounds chemical synthesis, Organoplatinum Compounds chemistry, Oximes chemistry, Reactive Oxygen Species metabolism, Salmon, Structure-Activity Relationship, Testis chemistry, Antineoplastic Agents pharmacology, Chelating Agents pharmacology, Drug Resistance, Neoplasm drug effects, Organophosphorus Compounds pharmacology, Organoplatinum Compounds pharmacology, Oximes pharmacology
- Abstract
Platinum(II) complexes of the type [Pt(Cl)(PPh
3 ){(κ2 -N,O)-(1{C(R)=N(OH)-2(O)C6 H4 })}] with R=Me, H, (1 and 2) were synthesized and characterized. Single-crystal X-ray diffraction confirmed the proposed (SP4-3) configuration for 1. Study of the antiproliferative activity, performed on a panel of human tumor cell lines and on mesothelial cells, highlighted complex 2 as the more effective. In particular, it showed a remarkable cytotoxicity in ovarian carcinoma cells (A2780) and interestingly, a significant antiproliferative effect on cisplatin resistant cells (A2780cis). Investigation into the intracellular mechanism of action demonstrated that 2 had a lower ability to platinate DNA than did cisplatin, which was taken as reference, and a notably higher uptake in resistant cells. A significant accumulation in mitochondria, along with the ability to induce concentration-dependent mitochondrial membrane depolarization and intracellular reactive oxygen species production, allowed us to propose a mitochondrion-mediated pathway as responsible for the interesting cytotoxic profile of complex 2., (© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.)- Published
- 2020
- Full Text
- View/download PDF
18. Identification of New Peptides from Fermented Milk Showing Antioxidant Properties: Mechanism of Action.
- Author
-
Tonolo F, Fiorese F, Moretto L, Folda A, Scalcon V, Grinzato A, Ferro S, Arrigoni G, Bindoli A, Feller E, Bellamio M, Marin O, and Rigobello MP
- Abstract
Due to their beneficial properties, fermented foods are considered important constituents of the human diet. They also contain bioactive peptides, health-promoting compounds studied for a wide range of effects. In this work, several antioxidant peptides extracted from fermented milk proteins were investigated. First, enriched peptide fractions were purified and analysed for their antioxidant capacity in vitro and in a cellular model. Subsequently, from the most active fractions, 23 peptides were identified by mass spectrometry MS/MS), synthesized and tested. Peptides N-15-M , E-11-F , Q-14-R and A-17-E were selected for their antioxidant effects on Caco-2 cells both in the protection against oxidative stress and inhibition of ROS production. To define their action mechanism, the activation of the Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2(Keap1/Nrf2) pathway was studied evaluating the translocation of Nrf2 from cytosol to nucleus. In cells treated with N-15-M , Q-14-R and A-17-E, a higher amount of Nrf2 was found in the nucleus with respect to the control. In addition, the three active peptides, through the activation of Keap1/Nrf2 pathway, led to overexpression and increased activity of antioxidant enzymes. Molecular docking analysis confirmed the potential ability of N-15-M , Q-14-R and A-17-E to bind Keap1, showing their destabilizing effect on Keap1/Nrf2 interaction., Competing Interests: The authors declare no conflict of interest.
- Published
- 2020
- Full Text
- View/download PDF
19. Small Structural Differences between Two Ferrocenyl Diphenols Determine Large Discrepancies of Reactivity and Biological Effects.
- Author
-
Tonolo F, Salmain M, Scalcon V, Top S, Pigeon P, Folda A, Caron B, McGlinchey MJ, Toillon RA, Bindoli A, Jaouen G, Vessières A, and Rigobello MP
- Subjects
- Antineoplastic Agents pharmacology, Cell Line, Tumor, Cell Survival drug effects, Coordination Complexes pharmacology, Enzyme Inhibitors pharmacology, Humans, Membrane Potential, Mitochondrial drug effects, Oxidation-Reduction, Antineoplastic Agents chemistry, Coordination Complexes chemistry, Enzyme Inhibitors chemistry, Ferrous Compounds chemistry, Thioredoxin-Disulfide Reductase antagonists & inhibitors
- Abstract
The ferrocenyl diphenol complexes 1,1-bis(4'-hydroxyphenyl)-2-ferrocenyl-but-1-ene (1) and 1,2-bis(4'-hydroxyphenyl)-1-ferrocenyl-but-1-ene [(Z)-2], which differ by the relative position of the two phenolic substituents, display dramatically different antiproliferative activities on cancer cells (1 is far more cytotoxic than 2). In this study, our goal was to discover the origin of this difference by comparing their reactivity and biological behaviour. In terms of common behaviour, we found that 1 and 2 are both efficient inhibitors of thioredoxin reductase (TrxR) in vitro after oxidation by a horseradish peroxidase/H
2 O2 system. However, as 1 is only a moderate inhibitor of TrxR in MDA-MB-231 cells, TrxR is probably not the major target responsible for the cytotoxicity of 1. In terms of differences, we noted that 1 induced a significant redox imbalance characterised by lipid peroxidation and thiol oxidation, and a moderate decrease of the mitochondrial membrane potential in breast cancer cells, whereas 2 has almost no effect. These results underline the importance of the trans configuration in the ferrocenyl-double bond-phenol motif, which is present in 1 but is cis in (Z)-2., (© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.)- Published
- 2019
- Full Text
- View/download PDF
20. Antioxidant Properties of Fermented Soy during Shelf Life.
- Author
-
Tonolo F, Moretto L, Folda A, Scalcon V, Bindoli A, Bellamio M, Feller E, and Rigobello MP
- Subjects
- Fermentation, Food Storage, Humans, Lipid Peroxidation, Nutritive Value, Oxidation-Reduction, Phenols analysis, Antioxidants analysis, Soy Foods analysis, Glycine max chemistry
- Abstract
Glycine max (soybean) is a fundamental food in human nutrition, largely utilized by the consumers, and in particular, fermented soy is mainly used. However, health benefits of the products can change during the shelf life as oxidation processes occur determining alterations of protein and lipid constituents leading to a decrease of nutritional quality. Therefore, the oxidative stability of the fermented soy during the shelf life was studied. The antioxidant potential of this product was evaluated by estimating total phenols, free radical scavenger activity using DPPH and ABTS tests, and the degree of lipid peroxidation, from I up to IX weeks. The antioxidant capacity after an initial decrease, increased again at VII-IX weeks. Lipid peroxidation was evaluated by comparing non fermented and fermented soy. The results disclosed a low amount of peroxides in the fermented soy, suggesting that fermentation brings to an improvement of the product associated to a decreased lipid peroxidation at longer times. Fractions of aqueous extract, obtained at the end of the shelf life from fermented soy, showed an enrichment in antioxidant peptides.
- Published
- 2019
- Full Text
- View/download PDF
21. Dimers of glutaredoxin 2 as mitochondrial redox sensors in selenite-induced oxidative stress.
- Author
-
Scalcon V, Tonolo F, Folda A, Bindoli A, and Rigobello MP
- Subjects
- Apoptosis, Glutaredoxins analysis, Glutathione metabolism, HeLa Cells, Humans, Iron metabolism, Oxidation-Reduction, Glutaredoxins metabolism, Mitochondria metabolism, Oxidative Stress, Protein Multimerization, Selenious Acid metabolism
- Abstract
Glutaredoxin 2 (Grx2) has been previously shown to link thioredoxin and glutathione systems receiving reducing equivalents by both thioredoxin reductase and glutathione. Grx2 catalyzes protein glutathionylation/de-glutathionylation and can coordinate an iron-sulfur cluster, forming inactive dimers stabilized by two molecules of glutathione. This protein is mainly located in the mitochondrial matrix, though other isoforms have been found in the cytosolic and nuclear cell compartments. In the present study, we have analyzed the monomeric and dimeric states of Grx2 under different redox conditions in HeLa cells, and sodium selenite was utilized as the principal oxidizing agent. After selenite treatment, an increased glutathione oxidation was associated to Grx2 monomerization and activation, specifically in the mitochondrial compartment. Interestingly, in mitochondria, a large decline of thioredoxin reductase activity was also observed concomitantly to Grx2 activity stimulation. In addition, Grx2 monomerization led to an increase free iron ions concentration in the mitochondrial matrix, induction of lipid peroxidation and decrease of the mitochondrial membrane potential, indicating that the disassembly of Grx2 dimer involved the release of the iron-sulfur cluster in the mitochondrial matrix. Moreover, sodium selenite-triggered lipid and protein oxidation was partially prevented by deferiprone, an iron chelator with mitochondriotropic properties, suggesting a role of the iron-sulfur cluster release in the observed impairment of mitochondrial functions. Thus, by sensing the overall cellular redox conditions, mitochondrial Grx2 dimers become active monomers upon oxidative stress induced by sodium selenite with the consequent release of the iron-sulfur cluster, leading to activation of the intrinsic apoptotic pathway.
- Published
- 2019
- Full Text
- View/download PDF
22. Insight into antioxidant properties of milk-derived bioactive peptides in vitro and in a cellular model.
- Author
-
Tonolo F, Moretto L, Ferro S, Folda A, Scalcon V, Sandre M, Fiorese F, Marin O, Bindoli A, and Rigobello MP
- Subjects
- Animals, Antioxidants chemical synthesis, Antioxidants chemistry, Caco-2 Cells, Cell Proliferation drug effects, Cells, Cultured, Computational Biology, Humans, Lipid Peroxidation drug effects, Peptides chemical synthesis, Peptides chemistry, Protein Conformation, Antioxidants pharmacology, Benzothiazoles antagonists & inhibitors, Biphenyl Compounds antagonists & inhibitors, Milk chemistry, Models, Biological, Peptides pharmacology, Picrates antagonists & inhibitors, Sulfonic Acids antagonists & inhibitors
- Abstract
Milk is a nutritionally important source of bioactive peptides with anti-inflammatory, immunomodulatory, anticancer, and antioxidant properties. These compounds can be useful as ingredients of functional food. For this reason, in the last decades, bioactive peptides attracted the interest of researchers and food companies. In this work, the results obtained with six milk-derived bioactive peptides (Y-4-R, V-6-R, V-7-K, A-10-F, R-10-M, and H-9-M) synthesized and studied for their antioxidant properties in vitro and in a cellular model, are reported. These molecules correspond to peptide fragments derived from parent compounds able to cross the apical membrane of Caco-2 cell layer and released in the basolateral compartment. In vitro, antioxidant tests such as 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) and crocin bleaching showed antioxidant activity mainly for peptides Y-4-R and V-6-R, respectively. In Caco-2 cells, peptides V-6-R, H-9-R, Y-4-R, and particularly R-10-M and V-7-K are able to prevent the decrease of viability due to oxidative stress. The latter peptide is also the most effective in protecting cells from lipid peroxidation. In conclusion, the reported hydrolyzed peptides are shown to exert the antioxidant properties both in vitro and in a cellular model., (© 2019 European Peptide Society and John Wiley & Sons, Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
23. Significance of the mitochondrial thioredoxin reductase in cancer cells: An update on role, targets and inhibitors.
- Author
-
Scalcon V, Bindoli A, and Rigobello MP
- Subjects
- Animals, Apoptosis physiology, Humans, Mitochondria enzymology, Neoplasms enzymology, Thioredoxin Reductase 2 metabolism
- Abstract
Thioredoxin reductase 2 (TrxR2) is a key component of the mitochondrial thioredoxin system able to transfer electrons to peroxiredoxin 3 (Prx3) in a reaction mediated by thioredoxin 2 (Trx2). In this way, both the level of hydrogen peroxide and thiol redox state are modulated. TrxR2 is often overexpressed in cancer cells conferring apoptosis resistance. Due to their exposed flexible arm containing selenocysteine, both cytosolic and mitochondrial TrxRs are inhibited by a large number of molecules. The various classes of inhibitors are listed and the molecules acting specifically on TrxR2 are extensively described. Particular emphasis is given to gold(I/III) complexes with phosphine, carbene or other ligands and to tamoxifen-like metallocifens. Also chemically unrelated organic molecules, including natural compounds and their derivatives, are taken into account. An important feature of many TrxR2 inhibitors is provided by their nature of delocalized lipophilic cations that allows their accumulation in mitochondria exploiting the organelle membrane potential. The consequences of TrxR2 inhibition are presented focusing especially on the impact on mitochondrial pathophysiology. Inhibition of TrxR2, by hindering the activity of Trx2 and Prx3, increases the mitochondrial concentration of reactive oxygen species and shifts the thiol redox state toward a more oxidized condition. This is reflected by alterations of specific targets involved in the release of pro-apoptotic factors such as cyclophilin D which acts as a regulator of the mitochondrial permeability transition pore. Therefore, the selective inhibition of TrxR2 could be utilized to induce cancer cell apoptosis., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
24. Corrigendum to "European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)" [Redox Biol. 13 (2017) 94-162].
- Author
-
Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G, Petry A, Schulz R, Vina J, Winyard P, Abbas K, Ademowo OS, Afonso CB, Andreadou I, Antelmann H, Antunes F, Aslan M, Bachschmid MM, Barbosa RM, Belousov V, Berndt C, Bernlohr D, Bertrán E, Bindoli A, Bottari SP, Brito PM, Carrara G, Casas AI, Chatzi A, Chondrogianni N, Conrad M, Cooke MS, Costa JG, Cuadrado A, My-Chan Dang P, De Smet B, Debelec-Butuner B, Dias IHK, Dunn JD, Edson AJ, El Assar M, El-Benna J, Ferdinandy P, Fernandes AS, Fladmark KE, Förstermann U, Giniatullin R, Giricz Z, Görbe A, Griffiths H, Hampl V, Hanf A, Herget J, Hernansanz-Agustín P, Hillion M, Huang J, Ilikay S, Jansen-Dürr P, Jaquet V, Joles JA, Kalyanaraman B, Kaminskyy D, Karbaschi M, Kleanthous M, Klotz LO, Korac B, Korkmaz KS, Koziel R, Kračun D, Krause KH, Křen V, Krieg T, Laranjinha J, Lazou A, Li H, Martínez-Ruiz A, Matsui R, McBean GJ, Meredith SP, Messens J, Miguel V, Mikhed Y, Milisav I, Milković L, Miranda-Vizuete A, Mojović M, Monsalve M, Mouthuy PA, Mulvey J, Münzel T, Muzykantov V, Nguyen ITN, Oelze M, Oliveira NG, Palmeira CM, Papaevgeniou N, Pavićević A, Pedre B, Peyrot F, Phylactides M, Pircalabioru GG, Pitt AR, Poulsen HE, Prieto I, Rigobello MP, Robledinos-Antón N, Rodríguez-Mañas L, Rolo AP, Rousset F, Ruskovska T, Saraiva N, Sasson S, Schröder K, Semen K, Seredenina T, Shakirzyanova A, Smith GL, Soldati T, Sousa BC, Spickett CM, Stancic A, Stasia MJ, Steinbrenner H, Stepanić V, Steven S, Tokatlidis K, Tuncay E, Turan B, Ursini F, Vacek J, Vajnerova O, Valentová K, Van Breusegem F, Varisli L, Veal EA, Yalçın AS, Yelisyeyeva O, Žarković N, Zatloukalová M, Zielonka J, Touyz RM, Papapetropoulos A, Grune T, Lamas S, Schmidt HHHW, Di Lisa F, and Daiber A
- Published
- 2018
- Full Text
- View/download PDF
25. Milk-derived bioactive peptides protect against oxidative stress in a Caco-2 cell model.
- Author
-
Tonolo F, Sandre M, Ferro S, Folda A, Scalcon V, Scutari G, Feller E, Marin O, Bindoli A, and Rigobello MP
- Subjects
- Animals, Antioxidants chemistry, Antioxidants pharmacology, Caco-2 Cells, Cattle, Glutathione metabolism, Glutathione Peroxidase metabolism, Glutathione Reductase metabolism, Humans, Hydrogen Peroxide adverse effects, Peptides chemistry, Protective Agents chemistry, Reactive Oxygen Species metabolism, Superoxide Dismutase metabolism, Milk chemistry, Oxidative Stress drug effects, Peptides pharmacology, Protective Agents pharmacology
- Abstract
Milk and milk-derived products are a relevant source of bioactive peptides, which are also potential components of functional foods. Bioactive peptides exert multiple actions including an antioxidant role. In the present paper, four synthetic peptides (NPYVPR, AVPYPQR, KVLPVPEK, and ARHPHPHLSFM), corresponding to milk-derived peptides were studied. Although with different features, as revealed by RP-HPLC chromatography and MS analysis, the obtained peptides were shown to be taken up by Caco-2 cells arranged in an epithelial monolayer formation. The four peptides were all able to preserve cell viability against induced oxidative stress indicating that they might have a role in the control of oxidative stress. Therefore, an estimation of total thiols and glutathione content was performed after cell treatment with oxidants like hydrogen peroxide (H
2 O2 ) or tert-butyl hydroperoxide (TbOOH). The peptides were able to prevent the decrease of both total thiols and glutathione induced by H2 O2 or TbOOH, and, in addition, they showed a protective effect on the thiol-related antioxidant enzymes thioredoxin reductase and glutathione reductase. Finally, they caused a decrease of ROS production induced by TbOOH in Caco-2 cells. The reported results highlight the relevant antioxidant role played by bioactive peptides in cells, which adds to other previously known properties.- Published
- 2018
- Full Text
- View/download PDF
26. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches.
- Author
-
Karaca Ö, Scalcon V, Meier-Menches SM, Bonsignore R, Brouwer JMJL, Tonolo F, Folda A, Rigobello MP, Kühn FE, and Casini A
- Subjects
- Animals, Antineoplastic Agents chemical synthesis, Antineoplastic Agents chemistry, Antineoplastic Agents pharmacology, Cell Line, Tumor, Coordination Complexes chemical synthesis, Coordination Complexes chemistry, DNA metabolism, Drug Stability, G-Quadruplexes, Glutathione Reductase antagonists & inhibitors, Humans, Hydrophobic and Hydrophilic Interactions, Ligands, Organogold Compounds chemistry, Rats, Reactive Oxygen Species metabolism, Silver chemistry, Solubility, Coordination Complexes pharmacology, Gold chemistry, Thioredoxin Reductase 1 antagonists & inhibitors, Thioredoxin Reductase 2 antagonists & inhibitors
- Abstract
We report here on the synthesis of a series of mono- and dinuclear gold(I) complexes exhibiting sulfonated bis(NHC) ligands and novel hydroxylated mono(NHC) Au(I) compounds, which were also examined for their biological activities. Initial cell viability assays show strong antiproliferative activities of the hydroxylated mono(NHC) gold compounds (8 > 9 > 10) against 2008 human ovarian cancer cells even after 1 h incubation. In order to gain insight into the mechanism of biological action of the gold compounds, their effect on the pivotal cellular target seleno-enzyme thioredoxin reductase (TrxR), involved in the maintenance of intracellular redox balance, was investigated in depth. The compounds' inhibitory effects on TrxR and glutathione reductase (GR) were studied comparatively, using either the pure proteins or cancer cell extracts. The results show a strong and selective inhibitory effect of TrxR, specifically for the hydroxyl-functionalized NHC gold(I) complexes (8-10). Valuable information on the gold compounds' molecular reactivity with TrxR was gained using the BIAM (biotin-conjugated iodoacetamide) assay and performing competition experiments by mass spectrometry (MS). In good agreement, both techniques suggest the binding affinity of the mono(NHC) Au(I) complexes toward selenols and thiols. Notably, for the first time, bis-carbene formation from mono-carbenes in buffered solution could be observed by MS, which may provide new insights into the speciation mechanisms of bioactive Au(I) NHC complexes. Furthermore, the compounds' interactions with another relevant in cellulo target, namely telomeric G-quadruplex DNA-a higher-order DNA structure playing key roles in telomere function-was investigated by means of FRET melting assays. The lack of interactions with this type of nucleic acid secondary structure support the idea of selective targeting of the hydrophilic Au(I) NHC compounds toward proteins such as TrxR.
- Published
- 2017
- Full Text
- View/download PDF
27. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
- Author
-
Jürgens S, Scalcon V, Estrada-Ortiz N, Folda A, Tonolo F, Jandl C, Browne DL, Rigobello MP, Kühn FE, and Casini A
- Subjects
- Antineoplastic Agents chemical synthesis, Antineoplastic Agents chemistry, Cell Line, Tumor, Cell Proliferation drug effects, Dose-Response Relationship, Drug, Drug Screening Assays, Antitumor, Enzyme Inhibitors chemical synthesis, Enzyme Inhibitors chemistry, Humans, Molecular Structure, Organogold Compounds chemical synthesis, Organogold Compounds chemistry, Oxidation-Reduction, Structure-Activity Relationship, Thioredoxin-Disulfide Reductase antagonists & inhibitors, Thioredoxin-Disulfide Reductase metabolism, Antineoplastic Agents pharmacology, Enzyme Inhibitors pharmacology, Organogold Compounds pharmacology
- Abstract
A family of cyclometalated Au(III) complexes featuring a tridentate C^N^C scaffold has been synthesized and characterized. Microwave assisted synthesis of the ligands has also been exploited and optimized. The biological properties of the thus formed compounds have been studied in cancer cells and demonstrate generally moderate antiproliferative effects. Initial mechanistic insights have also been gained on the gold complex [Au(C^N^C)(GluS)] (3), and support the idea that the thioredoxin system may be a target for this family of compounds together with other relevant intracellular thiol-containing molecules., (Copyright © 2017 Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
28. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).
- Author
-
Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G, Petry A, Schulz R, Vina J, Winyard P, Abbas K, Ademowo OS, Afonso CB, Andreadou I, Antelmann H, Antunes F, Aslan M, Bachschmid MM, Barbosa RM, Belousov V, Berndt C, Bernlohr D, Bertrán E, Bindoli A, Bottari SP, Brito PM, Carrara G, Casas AI, Chatzi A, Chondrogianni N, Conrad M, Cooke MS, Costa JG, Cuadrado A, My-Chan Dang P, De Smet B, Debelec-Butuner B, Dias IHK, Dunn JD, Edson AJ, El Assar M, El-Benna J, Ferdinandy P, Fernandes AS, Fladmark KE, Förstermann U, Giniatullin R, Giricz Z, Görbe A, Griffiths H, Hampl V, Hanf A, Herget J, Hernansanz-Agustín P, Hillion M, Huang J, Ilikay S, Jansen-Dürr P, Jaquet V, Joles JA, Kalyanaraman B, Kaminskyy D, Karbaschi M, Kleanthous M, Klotz LO, Korac B, Korkmaz KS, Koziel R, Kračun D, Krause KH, Křen V, Krieg T, Laranjinha J, Lazou A, Li H, Martínez-Ruiz A, Matsui R, McBean GJ, Meredith SP, Messens J, Miguel V, Mikhed Y, Milisav I, Milković L, Miranda-Vizuete A, Mojović M, Monsalve M, Mouthuy PA, Mulvey J, Münzel T, Muzykantov V, Nguyen ITN, Oelze M, Oliveira NG, Palmeira CM, Papaevgeniou N, Pavićević A, Pedre B, Peyrot F, Phylactides M, Pircalabioru GG, Pitt AR, Poulsen HE, Prieto I, Rigobello MP, Robledinos-Antón N, Rodríguez-Mañas L, Rolo AP, Rousset F, Ruskovska T, Saraiva N, Sasson S, Schröder K, Semen K, Seredenina T, Shakirzyanova A, Smith GL, Soldati T, Sousa BC, Spickett CM, Stancic A, Stasia MJ, Steinbrenner H, Stepanić V, Steven S, Tokatlidis K, Tuncay E, Turan B, Ursini F, Vacek J, Vajnerova O, Valentová K, Van Breusegem F, Varisli L, Veal EA, Yalçın AS, Yelisyeyeva O, Žarković N, Zatloukalová M, Zielonka J, Touyz RM, Papapetropoulos A, Grune T, Lamas S, Schmidt HHHW, Di Lisa F, and Daiber A
- Subjects
- Animals, European Union, Humans, Molecular Biology organization & administration, Molecular Biology trends, Oxidation-Reduction, Reactive Oxygen Species chemistry, Signal Transduction, Societies, Scientific, International Cooperation, Reactive Oxygen Species metabolism
- Abstract
The European Cooperation in Science and Technology (COST) provides an ideal framework to establish multi-disciplinary research networks. COST Action BM1203 (EU-ROS) represents a consortium of researchers from different disciplines who are dedicated to providing new insights and tools for better understanding redox biology and medicine and, in the long run, to finding new therapeutic strategies to target dysregulated redox processes in various diseases. This report highlights the major achievements of EU-ROS as well as research updates and new perspectives arising from its members. The EU-ROS consortium comprised more than 140 active members who worked together for four years on the topics briefly described below. The formation of reactive oxygen and nitrogen species (RONS) is an established hallmark of our aerobic environment and metabolism but RONS also act as messengers via redox regulation of essential cellular processes. The fact that many diseases have been found to be associated with oxidative stress established the theory of oxidative stress as a trigger of diseases that can be corrected by antioxidant therapy. However, while experimental studies support this thesis, clinical studies still generate controversial results, due to complex pathophysiology of oxidative stress in humans. For future improvement of antioxidant therapy and better understanding of redox-associated disease progression detailed knowledge on the sources and targets of RONS formation and discrimination of their detrimental or beneficial roles is required. In order to advance this important area of biology and medicine, highly synergistic approaches combining a variety of diverse and contrasting disciplines are needed., (Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
29. Oxidative changes in lipids, proteins, and antioxidants in yogurt during the shelf life.
- Author
-
Citta A, Folda A, Scalcon V, Scutari G, Bindoli A, Bellamio M, Feller E, and Rigobello MP
- Abstract
Oxidation processes in milk and yogurt during the shelf life can result in an alteration of protein and lipid constituents. Therefore, the antioxidant properties of yogurt in standard conditions of preservation were evaluated. Total phenols, free radical scavenger activity, degree of lipid peroxidation, and protein oxidation were determined in plain and skim yogurts with or without fruit puree. After production, plain, skim, plain berries, and skim berries yogurts were compared during the shelf life up to 9 weeks. All types of yogurts revealed a basal antioxidant activity that was higher when a fruit puree was present but gradually decreased during the shelf life. However, after 5-8 weeks, antioxidant activity increased again. Both in plain and berries yogurts lipid peroxidation increased until the seventh week of shelf life and after decreased, whereas protein oxidation of all yogurts was similar either in the absence or presence of berries and increased during shelf life. During the shelf life, a different behavior between lipid and protein oxidation takes place and the presence of berries determines a protection only against lipid peroxidation.
- Published
- 2017
- Full Text
- View/download PDF
30. Tamoxifen-like metallocifens target the thioredoxin system determining mitochondrial impairment leading to apoptosis in Jurkat cells.
- Author
-
Scalcon V, Salmain M, Folda A, Top S, Pigeon P, Shirley Lee HZ, Jaouen G, Bindoli A, Vessières A, and Rigobello MP
- Subjects
- Cytosol drug effects, Cytosol metabolism, Humans, Hydrogen Peroxide metabolism, Jurkat Cells, Membrane Potential, Mitochondrial drug effects, Mitochondria drug effects, Oxidation-Reduction drug effects, Selenocysteine metabolism, Subcellular Fractions metabolism, Tamoxifen chemistry, Thioredoxin-Disulfide Reductase metabolism, Apoptosis drug effects, Mitochondria metabolism, Tamoxifen pharmacology, Thioredoxins metabolism
- Abstract
Tamoxifen-like metallocifens (TLMs) of the group-8 metals (Fe, Ru, and Os) show strong anti-proliferative activity on cancer cell lines resistant to apoptosis, owing to their unique redox properties. In contrast, the thioredoxin system, which is involved in cellular redox balance, is often overexpressed in cancer cells, especially in tumour types resistant to standard chemotherapies. Therefore, we investigated the effect of these three TLMs on the thioredoxin system and evaluated the input of the metallocene unit in comparison with structurally related organic tamoxifens. In vitro, all three TLMs became strong inhibitors of the cytosolic (TrxR1) and mitochondrial (TrxR2) isoforms of thioredoxin reductase after enzymatic oxidation with HRP/H
2 O2 while none of the organic analogues was effective. In Jurkat cells, TLMs inhibited mainly TrxR2, resulting in the accumulation of oxidized thioredoxin 2 and cell redox imbalance. Overproduction of ROS resulted in a strong decrease in the mitochondrial membrane potential, translocation of cytochrome c to the cytosol and activation of caspase 3, thus leading to apoptosis. None of these events occurred with organic tamoxifens. The mitochondrial fraction of cells exposed to TLMs contained a high amount of the corresponding metal, as quantified by ICP-OES. The lipophilic and cationic character associated with the singular redox properties of the TLMs could explain why they alter the mitochondrial function. These results provide new insights into the mechanism of action of tamoxifen-like metallocifens, underlying their prodrug behaviour and the pivotal role played by the metallocenic entity in their cytotoxic activity associated with the induction of apoptosis.- Published
- 2017
- Full Text
- View/download PDF
31. Enzymatic oxidation of ansa-ferrocifen leads to strong and selective thioredoxin reductase inhibition in vitro.
- Author
-
Scalcon V, Citta A, Folda A, Bindoli A, Salmain M, Ciofini I, Blanchard S, de Jésús Cázares-Marinero J, Wang Y, Pigeon P, Jaouen G, Vessières A, and Rigobello MP
- Subjects
- Horseradish Peroxidase chemistry, Oxidation-Reduction, Saccharomyces cerevisiae Proteins chemistry, Thioredoxin-Disulfide Reductase chemistry, Ferrous Compounds chemistry, Saccharomyces cerevisiae enzymology, Saccharomyces cerevisiae Proteins antagonists & inhibitors, Thioredoxin-Disulfide Reductase antagonists & inhibitors
- Abstract
This paper reports the inhibitory effect on the cytosolic thioredoxin reductase (TrxR1) in vitro by the ansa-ferrocifen derivative (ansa-FcdiOH, 1). We found that 1 decreased only slightly enzyme activity (IC
50 =8μM), while 1*, the species generated by enzymatic oxidation by the HRP (horseradish peroxidase)/H2 O2 mixture, strongly inhibited TrxR1 (IC50 =0.15μM). At the same concentrations, neither 1 nor 1* had effect on glutathione reductase (GR). The most potent TrxR1 inhibitor did not appear to be the corresponding quinone methide as it was the case for ferrocifens of the acyclic series, or the stabilized carbocation as in the osmocifen series, but rather the quinone methide radical. This hypothesis was confirmed by ab-initio calculations of the species generated by oxidation of 1 and by EPR spectroscopy. BIAM (biotin-conjugated iodoacetamide) assay showed that 1* targeted both cysteine and selenocysteine of the C-terminal redox center of TrxR1., (Copyright © 2016 Elsevier Inc. All rights reserved.)- Published
- 2016
- Full Text
- View/download PDF
32. Comparative effects of selenate and selenite on selenium accumulation, morphophysiology, and glutathione synthesis in Ulva australis.
- Author
-
Schiavon M, Pilon-Smits EA, Citta A, Folda A, Rigobello MP, and Dalla Vecchia F
- Subjects
- Carotenoids metabolism, Chlorophyll metabolism, Ulva growth & development, Glutathione metabolism, Selenic Acid metabolism, Selenious Acid metabolism, Selenium metabolism, Ulva metabolism
- Abstract
The capacity of Ulva australis Areschoug to tolerate and accumulate selenium (Se) supplied in the form of selenate or selenite was investigated. The macroalga was provided for 3 and 7 days with concentrations of selenate (Na2SeO4) or selenite (Na2SeO3) ranging from 0 to 400 μM. U. australis exhibited the highest ability to accumulate selenium when fed with 100 μM selenate and 200 μM selenite after 7 days, and accumulation values were respectively 25 and 36 ppm Se. At the same concentrations, stimulation of the synthesis of chlorophylls and carotenoids was observed. Elevated doses of selenate or selenite decreased Se accumulation inside algal cells, perhaps through repression of membrane transporters. This effect was more pronounced in thalli cultivated with selenate. There were no morphological and ultrastructural alterations in thalli exposed to Se. However, selenite induced the increase of the oxidized fraction of glutathione (GSSG), perhaps because of its capacity to bind the thiol group of reduced glutathione (GSH). In conclusion, this study highlights the capacity of U. australis to resist to very high concentrations of selenite and selenate, which are normally toxic to other organisms. Also, the lack of bioconcentration in U. australis indicates that this alga does not facilitate delivery of Se in the food chain and remains safe for consumption when it grows in water bodies contaminated with Se. Its potential for the removal of excess Se from water bodies appears limited.
- Published
- 2016
- Full Text
- View/download PDF
33. Osmocenyl-tamoxifen derivatives target the thioredoxin system leading to a redox imbalance in Jurkat cells.
- Author
-
Scalcon V, Top S, Lee HZ, Citta A, Folda A, Bindoli A, Leong WK, Salmain M, Vessières A, Jaouen G, and Rigobello MP
- Subjects
- Antineoplastic Agents chemical synthesis, Cell Death drug effects, Coordination Complexes chemical synthesis, Ferrous Compounds chemical synthesis, Gene Expression, Glutathione metabolism, Humans, Indolequinones chemistry, Jurkat Cells, Membrane Potential, Mitochondrial drug effects, Mitochondria drug effects, Mitochondria metabolism, Organometallic Compounds chemical synthesis, Osmium chemistry, Oxidation-Reduction, Oxidative Stress, Peroxiredoxin III chemistry, Peroxiredoxin III metabolism, Reactive Oxygen Species agonists, Reactive Oxygen Species metabolism, Thioredoxin Reductase 1 genetics, Thioredoxin Reductase 1 metabolism, Thioredoxins chemistry, Thioredoxins metabolism, Antineoplastic Agents pharmacology, Coordination Complexes pharmacology, Ferrous Compounds pharmacology, Organometallic Compounds pharmacology, Tamoxifen chemistry, Thioredoxin Reductase 1 antagonists & inhibitors
- Abstract
The synthesis and the biological effects of two ferrocifen analogs in the osmium series, namely the monophenolic complex 1, the tamoxifen-like complex 2 and their oxidized quinone methide (QM) derivatives, 1-QM and 2-QM, are reported. Inhibition of purified thioredoxin reductase (TrxR) is observed with 1 and 2 only after their enzymatic oxidation by the hydrogen peroxide/horseradish peroxidase (H2O2/HRP) system with IC50 of 2.4 and 1.2μM respectively. However, this inhibition is larger than that obtained with the corresponding quinone methides (IC50=5.4μM for 1-QM and 3.6μM for 2-QM). The UV-Vis spectra of 1 or 2 incubated in the presence of H2O2/HRP show that the species generated is not a quinone methide, but probably the corresponding cation. In Jurkat cells, 2 shows high toxicity (IC50=7.4μM), while 1 is less effective (IC50=42μM). Interestingly, a significant inhibition of TrxR activity is observed in cells incubated with 2 (about 70% inhibition with 15μM) while the inhibition induced by 1 is much weaker (about 30% inhibition with 50μM). This strong inhibition of TrxR by 2 leads to accumulation of thioredoxin and peroxiredoxin 3 in oxidized form and to a decrease of the mitochondrial membrane potential (MMP). These results show that cytotoxicity of the osmocifens depends on their oxidation within the cell and that inhibition of thioredoxin reductase by oxidized species is a key factor in rationalizing the cytotoxicity of these complexes on Jurkat cells., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
34. Mitochondrial Thioredoxin System as a Modulator of Cyclophilin D Redox State.
- Author
-
Folda A, Citta A, Scalcon V, Calì T, Zonta F, Scutari G, Bindoli A, and Rigobello MP
- Subjects
- Animals, Auranofin pharmacology, Blotting, Western, Cell Line, Tumor, Peptidyl-Prolyl Isomerase F, Cyclophilins antagonists & inhibitors, Cyclophilins chemistry, Cyclosporine pharmacology, HeLa Cells, Humans, Hydrogen Peroxide metabolism, Hydrogen Peroxide pharmacology, Mitochondria, Heart genetics, Models, Molecular, Oxidants metabolism, Oxidants pharmacology, Oxidation-Reduction drug effects, Peroxiredoxin III chemistry, Protein Binding drug effects, Protein Domains, RNA Interference, Rats, Wistar, Reactive Oxygen Species metabolism, Thioredoxin Reductase 2 antagonists & inhibitors, Thioredoxin Reductase 2 genetics, Thioredoxin Reductase 2 metabolism, Thioredoxins chemistry, Cyclophilins metabolism, Mitochondria, Heart metabolism, Peroxiredoxin III metabolism, Thioredoxins metabolism
- Abstract
The mitochondrial thioredoxin system (NADPH, thioredoxin reductase, thioredoxin) is a major redox regulator. Here we have investigated the redox correlation between this system and the mitochondrial enzyme cyclophilin D. The peptidyl prolyl cis-trans isomerase activity of cyclophilin D was stimulated by the thioredoxin system, while it was decreased by cyclosporin A and the thioredoxin reductase inhibitor auranofin. The redox state of cyclophilin D, thioredoxin 1 and 2 and peroxiredoxin 3 was measured in isolated rat heart mitochondria and in tumor cell lines (CEM-R and HeLa) by redox Western blot analysis upon inhibition of thioredoxin reductase with auranofin, arsenic trioxide, 1-chloro-2,4-dinitrobenzene or after treatment with hydrogen peroxide. A concomitant oxidation of thioredoxin, peroxiredoxin and cyclophilin D was observed, suggesting a redox communication between the thioredoxin system and cyclophilin. This correlation was further confirmed by i) co-immunoprecipitation assay of cyclophilin D with thioredoxin 2 and peroxiredoxin 3, ii) molecular modeling and iii) depleting thioredoxin reductase by siRNA. We conclude that the mitochondrial thioredoxin system controls the redox state of cyclophilin D which, in turn, may act as a regulator of several processes including ROS production and pro-apoptotic factors release.
- Published
- 2016
- Full Text
- View/download PDF
35. Insights into the strong in-vitro anticancer effects for bis(triphenylphosphane)iminium compounds having perchlorate, tetrafluoridoborate and bis(chlorido)argentate anions.
- Author
-
Folda A, Scalcon V, Ghazzali M, Jaafar MH, Khan RA, Casini A, Citta A, Bindoli A, Rigobello MP, Al-Farhan K, Alsalme A, and Reedijk J
- Subjects
- Amino Acid Sequence, Animals, Antineoplastic Agents chemical synthesis, Antineoplastic Agents pharmacology, Cell Line, Tumor, DNA chemistry, Enzyme Inhibitors chemical synthesis, Enzyme Inhibitors pharmacology, Humans, Mitochondria drug effects, Molecular Sequence Data, Organometallic Compounds chemical synthesis, Organometallic Compounds pharmacology, Protein Binding, Rats, Thioredoxin-Disulfide Reductase chemistry, Thioredoxin-Disulfide Reductase metabolism, Antineoplastic Agents chemistry, Enzyme Inhibitors chemistry, Organometallic Compounds chemistry, Silver Compounds chemistry, Thioredoxin-Disulfide Reductase antagonists & inhibitors
- Abstract
Three new compounds containing the bis(triphenylphosphane)iminium cation (PPN(+)) with ClO4(-), BF4(-) and [AgCl2](-) as counter anions have been synthesized and structurally characterized. The two derivatives with ClO4(-) and BF4(-) were found to be isostructural by single crystal X-ray diffraction. Interestingly, the three compounds show extremely potent antiproliferative effects against the human cancer cell line SKOV3. To gain insights into the possible mechanisms of biological action, several intracellular targets have been considered. Thus, DNA binding has been evaluated, as well as the effects of the compounds on the mitochondrial function. Furthermore, the compounds have been tested as possible inhibitors of the seleno-enzyme thioredoxin reductase., (Copyright © 2015. Published by Elsevier Inc.)
- Published
- 2015
- Full Text
- View/download PDF
36. Gold(I) NHC-based homo- and heterobimetallic complexes: synthesis, characterization and evaluation as potential anticancer agents.
- Author
-
Bertrand B, Citta A, Franken IL, Picquet M, Folda A, Scalcon V, Rigobello MP, Le Gendre P, Casini A, and Bodio E
- Subjects
- Animals, Cell Line, Tumor, Copper, Glutathione Reductase antagonists & inhibitors, Humans, Organogold Compounds therapeutic use, Rats, Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins, Thioredoxin Reductase 1 antagonists & inhibitors, Thioredoxin Reductase 2 antagonists & inhibitors, Antineoplastic Agents chemical synthesis, Antineoplastic Agents therapeutic use, Enzyme Inhibitors chemical synthesis, Enzyme Inhibitors therapeutic use, Organogold Compounds chemical synthesis, Thioglucosides chemical synthesis, Thioglucosides therapeutic use
- Abstract
While N-heterocyclic carbenes (NHC) are ubiquitous ligands in catalysis for organic or industrial syntheses, their potential to form transition metal complexes for medicinal applications has still to be exploited. Within this frame, we synthesized new homo- and heterobimetallic complexes based on the Au(I)-NHC scaffold. The compounds were synthesized via a microwave-assisted method developed in our laboratories using Au(I)-NHC complexes carrying a pentafluorophenol ester moiety and another Au(I) phosphane complex or a bipyridine ligand bearing a pendant amine function. Thus, we developed two different methods to prepare homo- and heterobimetallic complexes (Au(I)/Au(I) or Au(I)/Cu(II), Au(I)/Ru(II), respectively). All the compounds were fully characterized by several spectroscopic techniques including far infrared, and were tested for their antiproliferative effects in a series of human cancer cells. They showed moderate anticancer properties. Their toxic effects were also studied ex vivo using the precision-cut tissue slices (PCTS) technique and initial results concerning their reactivity with the seleno-enzyme thioredoxin reductase were obtained.
- Published
- 2015
- Full Text
- View/download PDF
37. Evidence for targeting thioredoxin reductases with ferrocenyl quinone methides. A possible molecular basis for the antiproliferative effect of hydroxyferrocifens on cancer cells.
- Author
-
Citta A, Folda A, Bindoli A, Pigeon P, Top S, Vessières A, Salmain M, Jaouen G, and Rigobello MP
- Subjects
- Animals, Antineoplastic Agents therapeutic use, Cystamine analogs & derivatives, Cystamine chemistry, Ferrous Compounds therapeutic use, Glutathione metabolism, Glutathione Reductase antagonists & inhibitors, Glutathione Reductase metabolism, Humans, Indolequinones chemical synthesis, Inhibitory Concentration 50, Jurkat Cells, Metallocenes, Neoplasms drug therapy, Organoselenium Compounds chemistry, Rats, Selenocysteine chemistry, Ferrous Compounds chemistry, Indolequinones chemistry, Thioredoxin-Disulfide Reductase antagonists & inhibitors
- Abstract
Many anticancer compounds are strong inhibitors of thioredoxin reductases (TrxRs), selenoenzymes involved in cellular redox regulation. This study examined the effect of two hydroxyferrocifens (1, FcOH; 2, FcOHTAM) and of their corresponding quinone methides (QMs), 1-QM, and 2-QM, on these enzymes. In vitro, both QMs were more potent TrxR inhibitors (IC50 ≈ 2.5 μM) than the hydroxyferrocifens (IC50 ≈ 15 μM). This inhibition was due to a Michael addition of the penultimate selenocysteine residue of TrxRs to the QMs. In Jurkat cancer cells, both 2 and 2-QM inhibited TrxRs in the same proportion, leading to accumulation of oxidized forms of thioredoxin, while 1 and 1-QM were scarcely effective. This difference of behavior was ascribed to the competitive conversion of 1-QM to an inactive indene in protic medium. This set of experiments confirms for the first time the role played by ferrocenyl quinone methides on several biological targets and gives a molecular basis for these effects. It also highlights differences in the mechanisms of action of 1 and 2 in cancer cells.
- Published
- 2014
- Full Text
- View/download PDF
38. Myotonic dystrophy protein kinase (DMPK) prevents ROS-induced cell death by assembling a hexokinase II-Src complex on the mitochondrial surface.
- Author
-
Pantic B, Trevisan E, Citta A, Rigobello MP, Marin O, Bernardi P, Salvatori S, and Rasola A
- Subjects
- Cell Death, Gene Silencing, Humans, Isoenzymes metabolism, Muscle Fibers, Skeletal metabolism, Myotonin-Protein Kinase, Phosphorylation, Protein Binding, Superoxides metabolism, Hexokinase metabolism, Mitochondria enzymology, Protein Serine-Threonine Kinases metabolism, Reactive Oxygen Species metabolism, src-Family Kinases metabolism
- Abstract
The biological functions of myotonic dystrophy protein kinase (DMPK), a serine/threonine kinase whose gene mutations cause myotonic dystrophy type 1 (DM1), remain poorly understood. Several DMPK isoforms exist, and the long ones (DMPK-A/B/C/D) are associated with the mitochondria, where they exert unknown activities. We have studied the isoform A of DMPK, which we have found to be prevalently associated to the outer mitochondrial membrane. The kinase activity of mitochondrial DMPK protects cells from oxidative stress and from the ensuing opening of the mitochondrial permeability transition pore (PTP), which would otherwise irreversibly commit cells to death. We observe that DMPK (i) increases the mitochondrial localization of hexokinase II (HK II), (ii) forms a multimeric complex with HK II and with the active form of the tyrosine kinase Src, binding its SH3 domain and (iii) it is tyrosine-phosphorylated by Src. Both interaction among these proteins and tyrosine phosphorylation of DMPK are increased under oxidative stress, and Src inhibition selectively enhances death in DMPK-expressing cells after HK II detachment from the mitochondria. Down-modulation of DMPK abolishes the appearance of muscle markers in in vitro myogenesis, which is rescued by oxidant scavenging. Our data indicate that, together with HK II and Src, mitochondrial DMPK is part of a multimolecular complex endowed with antioxidant and pro-survival properties that could be relevant during the function and differentiation of muscle fibers.
- Published
- 2013
- Full Text
- View/download PDF
39. Fluorescent silver(I) and gold(I)-N-heterocyclic carbene complexes with cytotoxic properties: mechanistic insights.
- Author
-
Citta A, Schuh E, Mohr F, Folda A, Massimino ML, Bindoli A, Casini A, and Rigobello MP
- Subjects
- Animals, Cell Line, Tumor, Cell Survival, Cytosol enzymology, Dimerization, Drug Screening Assays, Antitumor, Glutathione Reductase chemistry, Humans, Liver enzymology, Methane chemistry, Microscopy, Fluorescence, Mitochondria enzymology, Mitochondria metabolism, Neoplasms metabolism, Oxidation-Reduction, Peroxiredoxin III chemistry, Rats, Reactive Oxygen Species, Thioredoxin-Disulfide Reductase chemistry, Thioredoxin-Disulfide Reductase metabolism, Gold chemistry, Methane analogs & derivatives, Neoplasms drug therapy, Silver chemistry
- Abstract
Silver(I) and gold(I)-N-heterocyclic carbene (NHC) complexes bearing a fluorescent anthracenyl ligand were examined for cytotoxicity in normal and tumor cells. The silver(I) complex exhibits greater cytotoxicity in tumor cells compared with normal cells. Notably, in cell extracts, this complex determines a more pronounced inhibition of thioredoxin reductase (TrxR), but it is ineffective towards glutathione reductase (GR). Both gold and silver complexes lead to oxidation of the thioredoxin system, the silver(I) derivative being particularly effective. In addition, the dimerization of peroxiredoxin 3 (Prx3) was also observed, demonstrating the ability of these compounds to reach the mitochondrial target. The fluorescence microscopy visualization of the subcellular distribution of the complexes shows a larger diffusion of these molecules in tumor cells with respect to normal cells.
- Published
- 2013
- Full Text
- View/download PDF
40. Principles in redox signaling: from chemistry to functional significance.
- Author
-
Bindoli A and Rigobello MP
- Subjects
- Animals, Humans, Peroxides metabolism, Reactive Nitrogen Species metabolism, Reactive Oxygen Species metabolism, Thioredoxins metabolism, Oxidation-Reduction, Signal Transduction
- Abstract
Reactive oxygen and nitrogen species are currently considered not only harmful byproducts of aerobic respiration but also critical mediators of redox signaling. The molecules and the chemical principles sustaining the network of cellular redox regulated processes are described. Special emphasis is placed on hydrogen peroxide (H(2)O(2)), now considered as acting as a second messenger, and on sulfhydryl groups, which are the direct targets of the oxidant signal. Cysteine residues of some proteins, therefore, act as sensors of redox conditions and are oxidized in a reversible reaction. In particular, the formation of sulfenic acid and disulfide, the initial steps of thiol oxidation, are described in detail. The many cell pathways involved in reactive oxygen species formation are reported. Central to redox signaling processes are the glutathione and thioredoxin systems controlling H(2)O(2) levels and, hence, the thiol/disulfide balance. Lastly, some of the most important redox-regulated processes involving specific enzymes and organelles are described. The redox signaling area of research is rapidly expanding, and future work will examine new pathways and clarify their importance in cellular pathophysiology.
- Published
- 2013
- Full Text
- View/download PDF
41. Inhibition of thioredoxin reductase by lanthanum chloride.
- Author
-
Citta A, Folda A, Scutari G, Cesaro L, Bindoli A, and Rigobello MP
- Subjects
- Catalytic Domain, Cell Line, Tumor, Cytosol metabolism, Dithionitrobenzoic Acid chemistry, Dose-Response Relationship, Drug, Glutathione Reductase metabolism, Humans, Kinetics, Lanthanum chemistry, Reactive Oxygen Species metabolism, Thioredoxin-Disulfide Reductase metabolism, Lanthanum pharmacology, Thioredoxin-Disulfide Reductase antagonists & inhibitors
- Abstract
Lanthanum chloride (LaCl(3)) is a good inhibitor of both the cytosolic and mitochondrial thioredoxin reductase with IC(50) values of 1.75 and 7.46 μM, respectively. On the contrary, the related enzyme glutathione reductase is not inhibited by lanthanum ions even at relatively high concentrations. In the presence of LaCl(3), steady-state kinetics shows a non-competitive type of inhibition with 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) as a substrate suggesting no interaction of this ion with the thiol/selenol active site of thioredoxin reductase. Comparison of the electrostatic surface potential of thioredoxin reductase shows that the presence of a trivalent cation such as La(3+) decreases the negatively charged area of the enzyme surface particularly in the region closed to the NADPH binding site. Human ovarian carcinoma cells (A2780 cells) incubated with lanthanum ions show a noticeable inhibition of thioredoxin reductase activity indicating the ability of this ion to reach the active site of the enzyme even in a cellular setting. In addition, A2780 cells treated with LaCl(3) show an increase in reactive oxygen species production in part dependent on thioredoxin reductase inhibition., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
42. Effects of redox modulation by inhibition of thioredoxin reductase on radiosensitivity and gene expression.
- Author
-
Selenius M, Hedman M, Brodin D, Gandin V, Rigobello MP, Flygare J, Marzano C, Bindoli A, Brodin O, Björnstedt M, and Fernandes AP
- Subjects
- Blotting, Western, Cell Cycle radiation effects, Cell Line, Humans, Lung Neoplasms pathology, Oxidation-Reduction, Phosphines pharmacology, RNA, Small Interfering genetics, RNA, Small Interfering metabolism, Radiation, Ionizing, Thioredoxin-Disulfide Reductase metabolism, Gold Compounds pharmacology, Radiation Tolerance, Thioredoxin-Disulfide Reductase antagonists & inhibitors, Up-Regulation
- Abstract
The thioredoxin system is a promising target when aiming to overcome the problem of clinical radiation resistance. Altered cellular redox status and redox sensitive thiols contributing to induction of resistance strongly connect the ubiquitous redox enzyme thioredoxin reductase (TrxR) to the cellular response to ionizing radiation. To further investigate possible strategies in combating clinical radiation resistance, human radio-resistant lung cancer cells were subjected to a combination of single fractions of γ-radiation at clinically relevant doses and non-toxic levels of a well-characterized thioredoxin reductase inhibitor, the phosphine gold(I) compound [Au(SCN)(PEt(3))]. The combination of the TrxR-inhibitor and ionizing radiation reduced the surviving fractions and impaired the ability of the U1810 cells to repopulate by approximately 50%. In addition, inhibition of thioredoxin reductase caused changes in the cell cycle distribution, suggesting a disturbance of the mitotic process. Global gene expression analysis also revealed clustered genetic expression changes connected to several major cellular pathways such as cell cycle, cellular response to stress and DNA damage. Specific TrxR-inhibition as a factor behind the achieved results was confirmed by correlation of gene expression patterns between gold and siRNA treatment. These results clearly demonstrate TrxR as an important factor conferring resistance to irradiation and the use of [Au(SCN)(PEt(3))] as a promising radiosensitizing agent., (© 2012 The Authors Journal of Cellular and Molecular Medicine © 2012 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.)
- Published
- 2012
- Full Text
- View/download PDF
43. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents.
- Author
-
Schuh E, Pflüger C, Citta A, Folda A, Rigobello MP, Bindoli A, Casini A, and Mohr F
- Subjects
- Antineoplastic Agents chemistry, Antineoplastic Agents pharmacology, Auranofin pharmacology, Benzimidazoles chemistry, Benzimidazoles pharmacology, Cell Extracts, Cell Line, Tumor, Coordination Complexes chemistry, Coordination Complexes pharmacology, Drug Screening Assays, Antitumor, Glutathione Reductase antagonists & inhibitors, Humans, Imidazoles chemistry, Imidazoles pharmacology, Oxidation-Reduction, Reactive Oxygen Species metabolism, Thioredoxin-Disulfide Reductase antagonists & inhibitors, Antineoplastic Agents chemical synthesis, Benzimidazoles chemical synthesis, Coordination Complexes chemical synthesis, Gold, Imidazoles chemical synthesis, Thioredoxins metabolism
- Abstract
Gold(I) complexes with 1,3-substituted imidazole-2-ylidene and benzimidazole-2-ylidene ligands of the type NHC-Au-L (NHC = N-heterocyclic carbene L = Cl or 2-mercapto-pyrimidine) have been synthesized and structurally characterized. The compounds were evaluated for their antiproliferative properties in human ovarian cancer cells sensitive and resistant to cisplatin (A2780S/R), as well in the nontumorigenic human embryonic kidney cell line (HEK-293T), showing in some cases important cytotoxic effects. Some of the complexes were comparatively tested as thioredoxin reductase (TrxR) and glutathione reductase (GR) inhibitors, directly against the purified proteins or in cell extracts. The compounds showed potent and selective TrxR inhibition properties in particular in cancer cell lines. Remarkably, the most effective TrxR inhibitors induced extensive oxidation of thioredoxins (Trxs), which was more relevant in the cancerous cells than in HEK-293T cells. Additional biochemical assays on glutathione systems and reactive oxygen species formation evidenced important differences with respect to the classical cytotoxic Au(I)-phosphine compound auranofin.
- Published
- 2012
- Full Text
- View/download PDF
44. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
- Author
-
Galassi R, Burini A, Ricci S, Pellei M, Rigobello MP, Citta A, Dolmella A, Gandin V, and Marzano C
- Subjects
- Antineoplastic Agents chemical synthesis, Antineoplastic Agents chemistry, Antineoplastic Agents pharmacology, Cell Line, Tumor, Drug Resistance, Multiple drug effects, Enzyme Inhibitors chemical synthesis, Enzyme Inhibitors chemistry, Enzyme Inhibitors pharmacology, Glutathione Reductase antagonists & inhibitors, Humans, Organogold Compounds chemistry, Chemistry Techniques, Synthetic methods, Organogold Compounds chemical synthesis, Organogold Compounds pharmacology, Phosphines chemistry, Thioredoxin-Disulfide Reductase antagonists & inhibitors
- Abstract
Following an increasing interest in the gold drug therapy field, nine new neutral azolate gold(I) phosphane compounds have been synthesized and tested as anticancer agents. The azolate ligands used in this study are pyrazolates and imidazolates substituted with deactivating groups such as trifluoromethyl, nitro or chloride moieties, whereas the phosphane co-ligand is the triphenylphosphane or the more hydrophilic TPA (TPA = 1,3,5-triazaphosphaadamantane). The studied gold(I) complexes are: (3,5-bis-trifluoromethyl-1H-pyrazolate-1-yl)-triphenylphosphane-gold(I) (1), (3,5-dinitro-1H-pyrazolate-1-yl)-triphenylphosphane-gold(I) (2), (4-nitro-1H-pyrazolate-1-yl)-triphenylphosphane-gold(I) (5), (4,5-dichloro-1H-imidazolate-1-yl)-triphenylphosphane-gold(I) (7), with the related TPA complexes (3), (4), (6) and (8) and (1-benzyl-4,5-di-chloro-2H-imidazolate-2-yl)-triphenylphosphane-gold(I) (9). The presence of deactivating groups on the azole rings improves the solubility of these complexes in polar media. Compounds 1-8 contain the N-Au-P environment, whilst compound 9 is the only one to contain a C-Au-P environment. Crystal structures for compounds 1 and 2 have been obtained and discussed. Interestingly, the newly synthesized gold(I) compounds were found to possess a pronounced cytotoxic activity on several human cancer cells, some of which were endowed with cis-platin or multidrug resistance. In particular, among azolate gold(I) complexes, 1 and 2 proved to be the most promising derivatives eliciting an antiproliferative effect up to 70 times higher than cis-platin. Mechanistic experiments indicated that the inhibition of thioredoxin reductase (TrxR) might be involved in the pharmacodynamic behavior of these gold species.
- Published
- 2012
- Full Text
- View/download PDF
45. Contrasting effects of selenite and tellurite on lipoamide dehydrogenase activity suggest a different biological behaviour of the two chalcogens.
- Author
-
Folda A, Citta A, Scutari G, Bindoli A, and Rigobello MP
- Subjects
- Animals, Enzyme Activators chemistry, HEK293 Cells, Humans, Oxidation-Reduction, Sodium Selenite chemistry, Sulfhydryl Compounds metabolism, Swine, Tellurium chemistry, Dihydrolipoamide Dehydrogenase antagonists & inhibitors, Dihydrolipoamide Dehydrogenase metabolism, Enzyme Activators pharmacology, Sodium Selenite pharmacology, Tellurium pharmacology
- Abstract
The effects of selenite and tellurite on the mammalian enzyme lipoamide dehydrogenase were compared. Selenite acts as a substrate of lipoamide dehydrogenase in a process requiring the presence of lipoamide. In contrast, tellurite is a potent inhibitor, effective in the low micromolar range. The inhibitory effect of tellurite on lipoamide dehydrogenase is partially reverted by dithiothreitol indicating the participation of the thiol groups of the enzyme. Tellurite, but not selenite, stimulates the diaphorase activity of lipoamide dehydrogenase. In a mitochondrial matrix protein preparation, which contains lipoamide dehydrogenase, an inhibitory action similar to that observed on the purified enzyme was also elicited by tellurite. Human embryonic kidney cells (HEK 293 T) treated with tellurite show a partial inhibition of lipoamide dehydrogenase. In addition to the toxicological implications of tellurium compounds, the reported results suggest that tellurite and its derivatives can be used as potential tools for studying biochemical reactions., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
46. Methylselenol formed by spontaneous methylation of selenide is a superior selenium substrate to the thioredoxin and glutaredoxin systems.
- Author
-
Fernandes AP, Wallenberg M, Gandin V, Misra S, Tisato F, Marzano C, Rigobello MP, Kumar S, and Björnstedt M
- Subjects
- Biological Transport, Cell Line, Tumor, Cell Survival drug effects, Cytochromes c metabolism, Disulfides metabolism, Glutathione analogs & derivatives, Glutathione metabolism, Humans, Intracellular Space metabolism, Methanol metabolism, Methanol pharmacology, Methylation, Organoselenium Compounds pharmacology, Oxidation-Reduction, Protein Binding, S-Adenosylmethionine metabolism, S-Adenosylmethionine pharmacology, Superoxides metabolism, Thioredoxin-Disulfide Reductase metabolism, Antineoplastic Agents metabolism, Antineoplastic Agents pharmacology, Glutaredoxins metabolism, Methanol analogs & derivatives, Organoselenium Compounds metabolism, Selenium Compounds metabolism, Selenium Compounds pharmacology, Thioredoxins metabolism
- Abstract
Naturally occurring selenium compounds like selenite and selenodiglutathione are metabolized to selenide in plants and animals. This highly reactive form of selenium can undergo methylation and form monomethylated and multimethylated species. These redox active selenium metabolites are of particular biological and pharmacological interest since they are potent inducers of apoptosis in cancer cells. The mammalian thioredoxin and glutaredoxin systems efficiently reduce selenite and selenodiglutathione to selenide. The reactions are non-stoichiometric aerobically due to redox cycling of selenide with oxygen and thiols. Using LDI-MS, we identified that the addition of S-adenosylmethionine (SAM) to the reactions formed methylselenol. This metabolite was a superior substrate to both the thioredoxin and glutaredoxin systems increasing the velocities of the nonstoichiometric redox cycles three-fold. In vitro cell experiments demonstrated that the presence of SAM increased the cytotoxicity of selenite and selenodiglutathione, which could neither be explained by altered selenium uptake nor impaired extra-cellular redox environment, previously shown to be highly important to selenite uptake and cytotoxicity. Our data suggest that selenide and SAM react spontaneously forming methylselenol, a highly nucleophilic and cytotoxic agent, with important physiological and pharmacological implications for the highly interesting anticancer effects of selenium.
- Published
- 2012
- Full Text
- View/download PDF
47. Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines.
- Author
-
Zanella A, Gandin V, Porchia M, Refosco F, Tisato F, Sorrentino F, Scutari G, Rigobello MP, and Marzano C
- Subjects
- Antineoplastic Agents chemical synthesis, Antineoplastic Agents chemistry, Cell Line, Tumor, Drug Screening Assays, Antitumor, Female, Humans, Membrane Potential, Mitochondrial drug effects, Mitochondria drug effects, Mitochondria pathology, Neoplasms pathology, Ovarian Neoplasms drug therapy, Ovarian Neoplasms pathology, Phosphines chemical synthesis, Phosphines chemistry, Reactive Oxygen Species metabolism, Structure-Activity Relationship, Antineoplastic Agents pharmacology, Copper chemistry, Neoplasms drug therapy, Phosphines pharmacology
- Abstract
Over the last few years a lot of research has been done to develop novel metal-based anti-cancer drugs, with the aim of improving clinical effectiveness, reducing general toxicity, and broadening the spectrum of activity. The search for novel metal-based antitumour drugs other than Pt agents includes the investigation of the cytotoxic activity of copper(I/II) compounds. Among these copper agents, particular attention has been recently devoted to hydrophilic copper(I) species bearing phosphines because of their noteworthy stability in aqueous media together with their remarkable in vitro cytotoxic activity. In this study we report on the synthesis, characterization and cytotoxic assays of a series of Cu(I) complexes with tris(2-cyanoethyl)phosphine (PCN) and bis(2-cyanoethyl)phenylphosphine (PCNPh). They were prepared by reaction of [Cu(CH(3)CN)(4)](+) or CuX(2) precursors with the pertinent phosphine in acetone or acetonitrile solutions producing compounds of the following formulation: [Cu(PCN)(2)](+) 2, [Cu(CH(3)CN)(PCN)](+) 3, [Cu(X)(PCN)] (X = Cl, 4; Br, 5), and [Cu(PCNPh)(2)](+) 6. The new copper(I) complexes were tested for their cytotoxic properties against a panel of several human tumour cell lines. Cellular copper uptake rate was correlated with cell growth inhibition in 2008 human ovarian cancer cells. Moreover, copper(I)-PCN complexes were evaluated for their ability to alter the most relevant mitochondrial pathophysiological parameters such as respiration, coupling, ATP-synthetase activity and membrane potential in isolated mitochondria. These data were correlated with changes in mitochondrial membrane potential and production of reactive oxygen species (ROS) in drug-treated 2008 cells.
- Published
- 2011
- Full Text
- View/download PDF
48. Interaction of selenite and tellurite with thiol-dependent redox enzymes: Kinetics and mitochondrial implications.
- Author
-
Rigobello MP, Folda A, Citta A, Scutari G, Gandin V, Fernandes AP, Rundlöf AK, Marzano C, Björnstedt M, and Bindoli A
- Subjects
- Animals, Auranofin pharmacology, Cell Line, Tumor, Cell Membrane Permeability drug effects, Female, Glutathione Reductase chemistry, Humans, Kinetics, Membrane Potential, Mitochondrial drug effects, Mitochondria, Liver drug effects, Mitochondria, Liver pathology, Ovarian Neoplasms drug therapy, Ovarian Neoplasms pathology, Oxidation-Reduction drug effects, Pyridines metabolism, Rats, Sodium Selenite chemistry, Substrate Specificity, Sulfhydryl Compounds metabolism, Tellurium chemistry, Thioredoxin-Disulfide Reductase chemistry, Yeasts, Glutathione Reductase metabolism, Mitochondria, Liver metabolism, Ovarian Neoplasms metabolism, Sodium Selenite pharmacology, Tellurium pharmacology, Thioredoxin-Disulfide Reductase metabolism
- Abstract
The interactions of selenite and tellurite with cytosolic and mitochondrial thioredoxin reductases (TrxR1 and TrxR2) and glutathione reductases (GR) from yeast and mammalian sources were explored. Both TrxR1 and TrxR2 act as selenite and tellurite reductases. Kinetic treatment shows that selenite has a greater affinity than tellurite with both TrxR1 and TrxR2. Considering both k(cat) and K(m), selenite shows a better catalytic efficiency than tellurite with TrxR1, whereas with TrxR2, the catalytic efficiency is similar for both chalcogens. Tellurite is a good substrate for GR, whereas selenite is almost completely ineffective. Selenite or tellurite determine a large mitochondrial permeability transition associated with thiol group oxidation. However, with increasing concentrations of both chalcogens, only about 25% of total thiols are oxidized. In isolated mitochondria, selenite or tellurite per se does not stimulate H₂O₂ production, which, however, is increased by the presence of auranofin. They also determine a large oxidation of mitochondrial pyridine nucleotides. In ovarian cancer cells both chalcogens decrease the mitochondrial membrane potential. These results indicate that selenite and tellurite, interacting with the thiol-dependent enzymes, alter the balance connecting pyridine nucleotides and thiol redox state, consequently leading to mitochondrial and cellular alterations essentially referable to a disulfide stress., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
49. In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands.
- Author
-
Santini C, Pellei M, Papini G, Morresi B, Galassi R, Ricci S, Tisato F, Porchia M, Rigobello MP, Gandin V, and Marzano C
- Subjects
- Animals, Cell Line, Tumor, Coordination Complexes chemical synthesis, Coordination Complexes chemistry, Drug Screening Assays, Antitumor, Humans, Hydrophobic and Hydrophilic Interactions, Inhibitory Concentration 50, Ligands, Proteasome Endopeptidase Complex, Proteasome Inhibitors, Rats, Structure-Activity Relationship, Thioredoxin-Disulfide Reductase antagonists & inhibitors, Cell Survival drug effects, Coordination Complexes pharmacology, Copper, Gold, Phosphines chemistry, Silver
- Abstract
Hydrophilic, monocationic [M(L)(4)]PF(6) complexes (M = Cu or Ag; L: thp = tris(hydroxymethyl)phosphine, L: PTA = 1,3,5-triaza-7-phosphaadamantane, L: thpp = tris(hydroxypropyl)phosphine) were synthesized by ligand exchange reaction starting from [Cu(CH(3)CN)(4)]PF(6) or AgPF(6) precursors at room temperature in the presence of an excess of the relevant phosphine. The related [Au(L)(4)]PF(6) complexes (L = thp, PTA or thpp) were synthesized by metathesis reactions starting from [Au(L)(4)]Cl at room temperature in the presence of equimolar quantity of TlPF(6). The three series of complexes [M(L)(4)]PF(6) were tested as cytotoxic agents against a panel of several human tumour cell lines also including a defined cisplatin resistant cell line. These investigations have been carried out in comparison with the clinically used metallodrug cisplatin and preliminary structure-activity relationships are presented. The best results in terms of in vitro antitumour activity were achieved with metal-thp species and, among the coinage metal complexes, copper derivatives were found to be the most efficient drugs. Preliminary studies concerning the mechanism of action of these [M(L)(4)]PF(6) species pointed to thioredoxin reductase as one of the putative cellular targets of gold and silver complexes and provided evidence that copper derivatives mediated their cytotoxic effect through proteasome inhibition., (Copyright © 2010 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
50. Hypericins and thioredoxin reductase: Biochemical and docking studies disclose the molecular basis for effective inhibition by naphthodianthrones.
- Author
-
Sorrentino F, Karioti A, Gratteri P, Rigobello MP, Scutari G, Messori L, Bindoli A, Chioccioli M, Gabbiani C, Bergonzi MC, and Bilia AR
- Subjects
- Amino Acid Sequence, Inhibitory Concentration 50, Kinetics, Models, Molecular, Molecular Sequence Data, Molecular Structure, Perylene pharmacology, Sequence Homology, Amino Acid, Thioredoxin-Disulfide Reductase chemistry, Thioredoxin-Disulfide Reductase metabolism, Anthracenes pharmacology, Perylene analogs & derivatives, Thioredoxin-Disulfide Reductase antagonists & inhibitors
- Abstract
Cytosolic (TrxR1) and mitochondrial (TrxR2) thioredoxin reductases experience pronounced concentration- and time-dependent inhibition when incubated with the two naphthodianthrones hypericin and pseudohypericin. Pseudohypericin turned out to be a quite strong inhibitor of TrxR1 (IC(50)=4.40μM) being far more effective than hypericin (IC(50)=157.08μM). In turn, the IC(50) values measured toward TrxR2 were 7.45μM for pseudohypericin and 43.12μM for hypericin. When compared to pseudohypericin, the inhibition caused by hypericin usually required significantly longer times, in particular on TrxR1. These important differences in the inhibitory potencies and profiles were analysed through a molecular modeling approach. Notably, both compounds were found to accommodate in the NADPH-binding pocket of the enzyme. The binding of the two naphthodianthrones to thioredoxin reductase seems to be particularly strong as the inhibitory effects were fully retained after gel filtration. Also, we found that TrxR inhibition by hypericin and pseudohypericin does not involve the active site selenol/thiol motif as confirmed by biochemical and modeling studies. The resulting inhibition pattern is very similar to that produced by the two naphthodianthrones on glutathione reductase. As the thioredoxin system is highly overexpressed in cancer cells, its inhibition by hypericin and pseudohypericin, natural compounds showing appreciable anticancer properties, might offer new clues on their mechanism of action and open interesting perspectives for future tumor therapies., (Copyright © 2010 Elsevier Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.